Synthetic peroxides as antimalarials

Current Opinion in Investigational Drugs

Volumn 5, Issue 8, 2004, Pages 866-872

  Jefford, Charles W ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

1*2*4*5 tetraoxanes; 1*2*4 trioxanes; 1,2 dioxanes; Arteflene; Bridged bicyclic peroxides; Chimerical molecules; Formulation; In vitro activity; In vivo Activity; Plasmodium; Resistance; Toxicity

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; OXIDIZING AGENT; PEROXIDE; SESQUITERPENE;

ANIMAL; DRUG RESISTANCE; HUMAN; MALARIA; PARASITOLOGY; REVIEW;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; HUMANS; MALARIA; OXIDANTS; PEROXIDES; SESQUITERPENES;

EID: 16644369226     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. WHO Expert Committee on Malaria: 20th Report. WHO Tech Rep Ser (2000):892-976.
2. Ridley RG, Dorn A, Vippagunta SR, Vennerstrom JL: Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ann Trop Med Parasitol (1997) 91(5):559-566.
3. Goodwin LG: Chemotherapy and tropical disease: The problem and the challenge. In: Chemotherapy of Tropical Diseases: Critical Reports on Applied Chemistry. Hooper M (Ed), John Wiley & Sons, Chichester, UK (1987) 21:1-18.
4. Horton RJ: Introduction of halofantrine for malaria treatment. Parasitology Today (1988) 4:238-239.
5. Hudson AT: Antimalarial hydroxynaphthoquinones. In: Topics in Medicinal Chemistry. Special publication No 65. Leeming PR (Ed), Royal Society of Chemistry, London, UK (1988):266-283.
6. Peters W: The prevention of antimalarial resistance. Pharmacol Ther (1990) 47(3):499-508.
7. White NJ: Combination treatment for falciparum prophylaxis. Lancet (1987) 1(8534):680-681.
8. Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stern R, Campbell CC: Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg (1986) 35(3):451-458.
9. McCullough KJ, Nojima M: Recent advances in the chemistry of cyclic peroxides. Curr Org Chem (2001) 5(6):601-636.
10. Jefford CW: Peroxidic antimalarials. In: Advances in Drug Research. Testa B, Meyer UA (Eds), Academic Press, Harcourt Brace and Company, London, UK (1997) 29:271- 325.
11. Jefford CW: Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action. Curr Med Chem (2001) 8(15):1803-1826.
12. Meshnick SR, Jefford CW, Posner GH, Avery MA, Peters W: Secondgeneration antimalarial endoperoxides. Parasitol Today (1996) 12(2):79-82.
13. Bell A: Recent developments in the chemotherapy of malaria. Curr Opin Anti-Infective Invest Drugs (2000) 2(1):63-70.
14. Vroman JA, Alvim-Gaston M, Avery MA: Current progress in the chemistry, medicinal chemistry and drug design of artemisininbased antimalarials. Curr Pharm Design (1999) 5(2):101-138.
15. Bhattacharya AK, Sharma RP: Recent developments on the chemistry and biological activity of artemisinin and related antimalarials - an update. Heterocycles (1999) 51:1681-1745.
16. Jung M: Current developments in the chemistry of artemisinin and related compounds. Curr Med Chem (1994) 1:35-49.
17. Jefford CW, Velarde J, Bernardinelli G: Synthesis of tricyclic arteannuinlike compounds. Tetrahedron Lett (1989) 30(34):4485-4488.
18. Jefford CW, Velarde JA, Bernardinelli G, Bray DH, Warhurst DC, Milhous WK: Synthesis, structure, and antimalarial activity of tricyclic 1,2,4-trioxanes related to artemisinin. Helv Chim Acta (1993) 76:2775-2788.
19. Posner GH, Cumming JN, Woo SH, Ploypradith P, Xie S, Shapiro TA: Orally active antimalarial 3-substituted trioxanes: New synthetic methodology and biological evaluation. J Med Chem (1998) 41(6):940-951.
20. Posner GH, Jeon HB, Parker MH, Krasavin M, Paik I, Shapiro TA: Antimalarial simplified 3-aryltrioxanes: Synthesis and preclinical efficacy/toxicity testing in rodents. J Med Chem (2001) 44(19):3054-3058.
21. Posner GH, Oh CH, Webster HK, Ager AL Jr, Rossan RN: New, antimalarial, tricyclic 1,2,4-trioxanes: Evaluations in mice and monkeys. Am J Trop Med Hyg (1994) 50(4):522-526.
22. Posner GH, McGarvey DJ, Oh CH, Kumar N, Meshnick SR, Asawamahasadka W: Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin. J Med Chem (1995) 38(4):607-612.
23. Hofheinz W, Bürgin H, Gocke E, Jaquet C, Masciadri R, Schmid G, Stohler H, Urwyler H: Ro 42-1611 (arteflene), a new effective antimalarial: Chemical structure and biological activity. Trop Med Parasitol (1994) 45(3):261-265.
24. Somo-Moyou R, Mittelholzer ML, Sorenson F, Haller L, Stürchler D: Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: A clinical trial in Cameroon. Trop Med Parasitol (1994) 45(3):288-291.
25. O'Neill PM, Searle NL, Raynes KJ, Maggs JL, Ward SA, Storr RC, Park BK, Posner GH: A carbonyl oxide route to antimalarial yingzhaosu A analogues: Synthesis and antimalarial activity. Tetrahedron Lett (1998) 39(33):6065-6068.
26. Bachi MD, Korshin EE, Ploypradith P, Cumming JN, Xie S, Shapiro TA, Posner GH: Synthesis and in vitro antimalarial activity of sulfone endoperoxides. Biorg Med Chem Lett (1998) 8(8):903-908.
27. Kim HS, Begum K, Ogura N, Wataya Y, Tokuyasu T, Masuyama A, Nojima M, McCullough KJ: Antimalarial activity of yingzhaosu A analogues. J Med Chem (2002) 45(21):4732-4736.
28. Tokuyasu T, Masuyama A, Nojima M, McCullough KJ, Kim H-S, Wataya Y: Yingzhaosu A analogues: Synthesis by the ozonolysis of unsaturated hydroperoxides, structural analysis and determination of antimalarial activity. Tetrahedron (2001) 57(28):5979-5989.
29. Jefford CW, Kohmoto S, Jaggi D, Timári G, Rossier JC, Rudaz M, Barbuzzi O, Gérard D, Burger U, Kamalaprija P, Mareda J et al: Synthesis, structure, and antimalarial activity of some enantiomerically pure cis-fused cyclopenteno-1,2,4-trioxanes. Helv Chim Acta (1995) 78:647-662.
30. Fleck SL, Robinson BL, Peters W, Thévin F, Boulard Y, Glénat C, Caillard V, Landau I: The chemotherapy of rodent malaria. LIII. 'Fenozan BO7 (Fenozan-50F), a difluorinated 3,3′-spirocyclopentane- 1,2,4-trioxane: Comparison with some compounds of the artemisinin series. Ann Trop Med Parasitol (1997) 91(1):25-32.
31. Hong YL, Yang YZ, Meshnick SR: The interaction of artemisinin with malarial hemozoin. Mol Biochem Parasitol (1994) 63(1):121-128.
32. Pandey AV, Tekwani BL, Singh RL, Chauhan VS: Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J Biol Chem (1999) 274(27):19383-19388.
33. Jefford CW, McGoran EC, Boukouvalas J, Richardson G, Robinsion BL, Peters W: Synthesis of new 1,2,4-trioxanes and their antimalarial activity. Helv Chim Acta (1988) 71:1805-1812.
34. Dechy-Cabaret O, Benoit-Vical F, Robert A, Meunier B: Preparation and antimalarial activities of 'trioxaquines', new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. ChemBioChem (2000) 1(4):281-283.
35. Jefford CW, Rossier JC, Milhous WK: The structure and antimalarial activity of some 1,2,4-trioxanes, 1,2,4,5-tetroxanes, and bicyclic endoperoxides: Implications for the mode of action. Heterocycles (2000) 52:1345-1352.
36. Doorenbos HE, Decker DL: Antimalarial synthesis. Annual Technical report No AM- 1A-73. The Dow Chemical Company (1973):14.
37. Vennerstrom JL, Fu H-N, Ellis WY, Ager AL Jr, Wood JK, Andersen SL, Gerena L, Milhous WK: Dispiro-1,2,4,5-tetraoxanes: A new class of antimalarial peroxides. J Med Chem (1992) 35(16):3023-3027.
38. Vennerstrom JL, Dong Y, Andersen SL, Ager AL Jr, Fu H, Miller RE, Wesche DL, Kyle DE, Gerena L, Walters SM, Wood JK et al: Synthesis and antimalarial activity of sixteen dispiro-1,2,4,5-tetraoxanes: Alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecanes. J Med Chem (2000) 43(14):2753-2758.
39. Dong Y, Matile H, Chollet J, Kaminsky R, Wood JK, Vennerstrom JL: Synthesis and antimalarial activity of 11 dispiro-1,2,4,5-tetraoxane analogues of WR 148999. 7,8,15,16-Tetraoxadispiro[5.2.5.2]-hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups. J Med Chem (1999) 42(8):1477-1480.
40. Kim HS, Shibata Y, Wataya Y, Tsuchiya K, Masuyama A, Nojima M: Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5,7- pentoxocanes and 1,2,4,5-tetroxanes. J Med Chem (1999) 42(14):2604-2609.
41. Kim HS, Nagai Y, Ono K, Begum K, Wataya Y, Hamada Y, Tsuchiya, K, Masuyama A, Nojima M, McCullough KJ: Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. J Med Chem (2001) 44(14):2357-2361.
42. Hamada Y, Tokuhara H, Masuyama A, Nojima M, Kim HS, Ono K, Ogura N, Wataya Y: Synthesis and notable antimalarial activity of acyclic peroxides, 1-(alkyldioxy)-1-(methyldioxy)cyclododecanes. J Med Chem (2002) 45(6):1374-1378.
43. O'Neill PM, Pugh M, Davies J, Ward SA, Park BK: Regioselective Mukaiyama hydroperoxysilylation of 2-alkyl- or 2-aryl-prop-2-ene-1-ols: Application to a new synthesis of 1,2,4-trioxanes. Tetrahedron Lettw (2001) 42(27):4569-4571.
44. Posner GH, O'Dowd H, Ploypradith P, Cumming JN, Xie S, Shapiro TA: Antimalarial cyclic peroxy ketals. J Med Chem (1998) 41(12):2164-2167.
45. Singh C, Gupta N, Puri SK: Photo-oxygenation of geraniol: Synthesis of a novel series of hydroxy-functionalized antimalarial 1,2,4-trioxanes. Bioorg Med Chem Lett (2002) 12(15):1913-1916.
46. Griesbeck AG, El-Idressy TT, Fiege M, Brun R: Synthesis of antimalarial 1,2,4-trioxanes via photooxygenation of a chiral allylic alcohol. Org Lett (2002) 4(24):4193- 4195.
47. Casteel DA, Jung KE, Gerena L, Milhous W: Synthesis and antimalarial evaluation of 2,3,5-trioxabicyclo[2.2.2]octanes, models for the putative pharmacophore of qinghaosu (artemisinin). Bioorg Med Chem (1992) 2:623-626.
48. Peters W, Fleck SL, Robinson BL, Stewart LB, Jefford CW: The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials. Ann Trop Med Parasitol (2002) 96(6):559-573.
49. Peters W, Robinson BL: The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. Ann Trop Med Parasitol (1999) 93(4):325-339.
50. Park BK, O'Neil PM, Maggs JL, Pirmohamed M: Safety assessment of peroxide antimalarials: Clinical and chemical perspectives. Br J Clin Pharmacol (1998) 46(6):521-529.
51. van Agtmael MA, Eggelte TA, van Boxtel CJ: Artemisinin drugs in the treatment of malaria: From medicinal herb to registered medication. Trends Pharmacol Sci (1999) 20(5):199-205.
52. Girometta MA, Jauch R, Ponelle C, Guenzi A, Chou RC: Animal pharmacokinetics and metabolism of the new antimalarial Ro 42-1611 (arteflene). Trop Med Parasitol (1994) 45(3):272-277.